Chestal Cold And Cough Tablet
NDC Package 0220-9111-04
Package Information
Chestal Cold And Cough (solanum dulcamara top; ferrosoferric phosphate, goldenseal, potassium dichromate, strychnos nux-vomica seed) tablets is uses* temporarily relieves symptoms of the common cold such as: ▪ nasal and chest congestion ▪ fitful cough ▪ sneezing ▪ occasional minor sore throat ▪ runny or stuffy nose. This formulation utilizes a tablet delivery system. Marketed by Boiron, this product is identified by NDC 0220-9111.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 0220 - Boiron
- 0220-9111 - Chestal Cold And Cough
- 0220-9111-04 - 3 BLISTER PACK in 1 CARTON / 20 TABLET in 1 BLISTER PACK
- 0220-9111 - Chestal Cold And Cough
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0220-9111-04 identifies a specific commercial package of 3 blister pack in 1 carton / 20 tablet in 1 blister pack of Chestal Cold And Cough, a human over the counter drug labeled by Boiron. This tablet is formulated for oral use and contains ferrosoferric phosphate; goldenseal; potassium dichromate; solanum dulcamara top; strychnos nux-vomica seed as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Boiron on March 20, 2026. The current certification is valid through December 31, 2027.
How is this Boiron product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00220911104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.